These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 310169)

  • 1. Depression of 'high affinity' T-cell rosettes indicative of recurrent carcinoma.
    Weese J; West W; Herberman R; Turcotte JG
    Surg Forum; 1977; 28():155-7. PubMed ID: 310169
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of circulating lung tumor antigen-sensitive T lymphocytes in the early stages of lung cancer.
    Ramey WG; Hashim GA; Munther AS; Swistel AJ; Burrows WB; Fitzpatrick HF
    Surgery; 1980 Aug; 88(2):202-7. PubMed ID: 6967233
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the mechanism of T-cell depression following radiotherapy or surgery for stage III breast cancer.
    Shukla HS; Whitehead RH; Hughes LE
    Clin Oncol; 1980 Mar; 6(1):39-47. PubMed ID: 6966205
    [No Abstract]   [Full Text] [Related]  

  • 4. "High-affinity" T-cell rosettes: the effects of clinical manipulations and potential prognostic significance.
    Weese JL; West WH; Herberman RB; Payne SM; Siwarski JW; Turcotte JG
    J Surg Oncol; 1980; 13(2):145-53. PubMed ID: 6965745
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
    Saiz-Garcia F; Rodriguez-Valverde V
    Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
    [No Abstract]   [Full Text] [Related]  

  • 6. E-rosette inhibition and tumour recurrence in early breast cancer.
    Haffejee AA; Webster DJ; Paterson AG; Whitehead RH; Thatcher J; Hughes LE; Angorn IB
    Br J Surg; 1983 Jun; 70(6):319-21. PubMed ID: 6602641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of antibody synthesis and expression of T-cell membrane markers by serum factors of patients with small cell carcinoma of the lung.
    Manke HG; Aulenbacher P; Rüster S; Drings P
    Anticancer Res; 1986; 6(4):869-73. PubMed ID: 3019227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of breast tumor antigen-sensitive circulating T-lymphocytes by antigen-stimulated active rosette formation.
    Ramey WG; Hashim GA; Burrows WB; Swistel AJ; Munther A; Fitzpatrick HF
    Cancer Res; 1979 Dec; 39(12):4796-801. PubMed ID: 315272
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of T-cell population in carcinoma breast.
    Nirwan PS; Ramdeo IN; Solanki RL
    Indian J Cancer; 1980 Dec; 17(4):210-5. PubMed ID: 6262220
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis, stage, and prognosis of lung carcinoma by preoperative assay of lung tumor antigen-sensitive T lymphocytes.
    Ramey WG; Fitzpatrick HF; Hashim GA; Munther AS; Swistel AJ; Burrows WB
    J Thorac Cardiovasc Surg; 1980 Nov; 80(5):656-60. PubMed ID: 6968856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
    Boyages J; Delaney G; Taylor R
    Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of determining the total E-rosettes in the pleural fluid].
    Mihăiescu T; Kalinca N; Celeki R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1986; 35(4):333-9. PubMed ID: 3031804
    [No Abstract]   [Full Text] [Related]  

  • 13. [CEA (carcinoembryonic antigen) in breast cancer. Clinical value].
    Villani C
    Minerva Med; 1981 Dec; 72(49):3315-22. PubMed ID: 7312207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Active" rosettes and skin tests to recall antigens and phytohemagglutinin in 48 patients with non metastatic squamous cell lung carcinoma and before treatment (author's transl)].
    Lang JM; Pauli G; Roeslin N; Bigel P; Bessot JC
    Rev Fr Mal Respir; 1980; 8(1):11-6. PubMed ID: 6970392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of carcinoma of the breast.
    Bond WH
    Mod Trends Radiother; 1972; 2():165-75. PubMed ID: 5076019
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro effect of thymosin on T cells from immunodepressed surgical patients.
    Hardy MA; Freund M; Friedmann N
    Surgery; 1976 Aug; 80(2):238-45. PubMed ID: 1085039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thymosin on T-lymphocyte rosette formation in Nigerian patients with different types of cancer.
    Olusi SO; Oluwole SF; Odesanmi WO
    Afr J Med Med Sci; 1984; 13(3-4):103-9. PubMed ID: 6099969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of several tumor markers in the chest surgery].
    Miyazato I; Tojo N
    Rinsho Kyobu Geka; 1988 Jun; 8(3):231-6. PubMed ID: 9301836
    [No Abstract]   [Full Text] [Related]  

  • 19. The possibility of accurate prediction of recurrence rates after mastectomy.
    Bulbrook RD; Wang DY; Millis RR; Hayward JL
    Eur J Cancer (1965); 1980; Suppl 1():35-6. PubMed ID: 7032942
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrative tumor board: recurrent breast cancer or new primary? Radiation oncology.
    Hirsch A
    Integr Cancer Ther; 2003 Sep; 2(3):272-6. PubMed ID: 15035891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.